NYSEAMERICAN:CVRS - Corindus Vascular Robotics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.31 -0.01 (-0.76 %)
(As of 02/20/2019 04:00 PM ET)
Previous Close$1.32
Today's Range$1.29 - $1.38
52-Week Range$0.70 - $1.65
Volume637,000 shs
Average Volume337,041 shs
Market Capitalization$250.63 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

Receive CVRS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVRS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:CVRS
Previous SymbolNYSEMKT:CVRS
CUSIPN/A
Phone+1-508-6533335

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees106
Market Cap$250.63 million
OptionableNot Optionable

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions

What is Corindus Vascular Robotics' stock symbol?

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) released its earnings results on Tuesday, August, 7th. The medical equipment provider reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.01. The medical equipment provider had revenue of $1.67 million for the quarter, compared to analysts' expectations of $3 million. View Corindus Vascular Robotics' Earnings History.

When is Corindus Vascular Robotics' next earnings date?

Corindus Vascular Robotics is scheduled to release their next quarterly earnings announcement on Wednesday, March 13th 2019. View Earnings Estimates for Corindus Vascular Robotics.

What price target have analysts set for CVRS?

3 equities research analysts have issued 1-year price objectives for Corindus Vascular Robotics' stock. Their predictions range from $1.00 to $2.00. On average, they anticipate Corindus Vascular Robotics' stock price to reach $1.6667 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Corindus Vascular Robotics.

What is the consensus analysts' recommendation for Corindus Vascular Robotics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Corindus Vascular Robotics.

Has Corindus Vascular Robotics been receiving favorable news coverage?

News stories about CVRS stock have been trending neutral recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Corindus Vascular Robotics earned a news sentiment score of 0.3 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next few days.

Are investors shorting Corindus Vascular Robotics?

Corindus Vascular Robotics saw a increase in short interest in January. As of January 31st, there was short interest totalling 13,318,394 shares, an increase of 1.4% from the January 15th total of 13,133,613 shares. Based on an average trading volume of 360,423 shares, the days-to-cover ratio is presently 37.0 days. Currently, 15.9% of the shares of the company are sold short. View Corindus Vascular Robotics' Current Options Chain.

Who are some of Corindus Vascular Robotics' key competitors?

Who are Corindus Vascular Robotics' key executives?

Corindus Vascular Robotics' management team includes the folowing people:
  • Mr. Mark J. Toland, CEO, Pres & Director (Age 49)
  • Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 49)
  • Mr. Tal Wenderow, Co-Founder and Exec. VP of International & Bus. Devel.
  • Mr. Douglas Teany, Chief Operating Officer
  • Ms. Nora Dutta, VP of HR

Who are Corindus Vascular Robotics' major shareholders?

Corindus Vascular Robotics' stock is owned by many different of retail and institutional investors. Top institutional investors include Millennium Management LLC (3.71%), Nomura Holdings Inc. (0.66%), Barclays PLC (0.20%), Virtu Financial LLC (0.04%), HRT Financial LLC (0.03%) and Jane Street Group LLC (0.02%). Company insiders that own Corindus Vascular Robotics stock include Healthcor Management, LP, Louis A Cannon and Philips Nv Koninklijke. View Institutional Ownership Trends for Corindus Vascular Robotics.

Which institutional investors are selling Corindus Vascular Robotics stock?

CVRS stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC. View Insider Buying and Selling for Corindus Vascular Robotics.

Which institutional investors are buying Corindus Vascular Robotics stock?

CVRS stock was purchased by a variety of institutional investors in the last quarter, including Barclays PLC, Nomura Holdings Inc., Virtu Financial LLC, Millennium Management LLC, HRT Financial LLC and Jane Street Group LLC. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Healthcor Management, LP and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corindus Vascular Robotics' stock price today?

One share of CVRS stock can currently be purchased for approximately $1.31.

How big of a company is Corindus Vascular Robotics?

Corindus Vascular Robotics has a market capitalization of $250.63 million. Corindus Vascular Robotics employs 106 workers across the globe.

What is Corindus Vascular Robotics' official website?

The official website for Corindus Vascular Robotics is http://www.corindus.com/.

How can I contact Corindus Vascular Robotics?

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.


MarketBeat Community Rating for Corindus Vascular Robotics (NYSEAMERICAN CVRS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  281 (Vote Outperform)
Underperform Votes:  348 (Vote Underperform)
Total Votes:  629
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe CVRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVRS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel